首页> 外文期刊>Statistics in Biosciences >A Data Augmentation Method for Estimating the Causal Effect of Adherence to Treatment Regimens Targeting Control of an Intermediate Measure
【24h】

A Data Augmentation Method for Estimating the Causal Effect of Adherence to Treatment Regimens Targeting Control of an Intermediate Measure

机译:一种估计数据量的方法,该方法用于估计针对中间措施的治疗方案的依从性的因果关系

获取原文
获取原文并翻译 | 示例
           

摘要

A dynamic treatment regimen is a rule or set of rules which define how a subject’s treatment at repeated visits depends on their evolving history of time-dependent covariates. In this manuscript we focus on regimens that are characterized by intermediate target ranges [b 1,b 2] which are used clinically to modify treatment such that longitudinal measures of the intermediate stay within a tolerance defined by [b 1,b 2]. For observational data, survival under a particular regimen can be consistently estimated by artificially censoring subjects when they become nonadherent to the regimen and then weighting subjects by the inverse probability of remaining uncensored. In many settings subjects are not identified at baseline as individuals who are following a pre-specified regimen. In addition, it may be possible for subjects to be adherent to multiple regimens at the same time. In order to compare alternative regimens we present a data augmentation methodology in which regimen membership is stochastically imputed multiple times and parameter estimates are aggregated to provide a final point estimate of a causal hazard ratio, and for which sandwich variance estimation methods provide consistent inference. The method is illustrated through simulation results as well as a preliminary analysis comparing epoetin therapy regimens with different target hemoglobin ranges in a cohort of hemodialysis subjects from the United States Renal Data System.
机译:动态治疗方案是一个规则或一组规则,用于定义对象在重复访问中的治疗方式如何取决于他们随时间变化的协变量的发展历史。在本手稿中,我们重点研究以中间目标范围[b 1 ,b 2 ]为特征的治疗方案,这些目标范围可在临床上用于修改治疗方法,从而对中间停留进行纵向测量在[b 1 ,b 2 ]定义的公差范围内。对于观察数据,可以通过在对象不遵循该方案时人为地审查对象,然后通过保持未经审查的逆概率对对象加权来一致地估计特定方案下的生存率。在许多情况下,在基线时并未将受试者识别为遵循预定方案的个体。另外,受试者可能同时遵守多种方案。为了比较替代方案,我们提出了一种数据扩充方法,其中方案成员数是随机估算的,并且参数估计值被汇总以提供因果风险比的最终点估计值,并且三明治方差估计方法可提供一致的推论。通过仿真结果以及对来自美国肾脏数据系统的一组血液透析受试者中具有不同目标血红蛋白范围的依泊汀治疗方案进行比较的初步分析说明了该方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号